患者様やご家族など一般の方向け臨床・治癒情報サイト 臨床研究情報ポータルサイト

ENGLISH
×

情報をクリップできます

治験情報をこちらのホームページで一時的にクリップすることが出来ます。

海外の治験の状況「1」での検索結果

絞り込み

11979件の検索結果
  • 進捗状況
  • 試験名
  • 対象疾患名
  • 地域
  • 登録日
  •  
  • Not Recruiting

  • DEFEND-1 Long Term Follow Up: Durable-Response Therapy Evaluation for Early or New Onset Type 1 Diabetes Extension Study - LTFU
  • Otelixizumab iis being developed for the treatment of patients with autoimmune T1DM with residual beta cell function (RBCF), for the purpose of preserving RBCF in this patient population. Currently there are no approved treatments for this indication. n the USA, the approved treatments for T1DM are insulin or insulin analogues. MedDRA version: 12.1 Level: LLT Classification code 10012608 Term: Diabetes mellitus insulin-dependent
  • Denmark, Finland, Germany, Spain, Sweden, United Kingdom
  • 2010-11-23
  • Not recruiting

  • Effect of MD1003 in Amyotrophic Lateral Sclerosis
  • ALS;Amyotrophic Lateral Sclerosis;Motor Neuron Disease;ALS;Amyotrophic Lateral Sclerosis;Motor Neuron Disease;ALS;Amyotrophic Lateral Sclerosis;Motor Neuron Disease;ALS;Amyotrophic Lateral Sclerosis;Motor Neuron Disease
  • France
  • 2017-03-28